Monoclonal antibody F16 I 124 - Philogen

Drug Profile

Monoclonal antibody F16 I 124 - Philogen

Alternative Names: 124I-F16; 124I-F16SIP; F16-I-124; Iodine-124-labelled F-16 scFv antibody; Monoclonal antibody F-16-I-124; Tenapet

Latest Information Update: 16 Feb 2016

Price : $50

At a glance

  • Originator Philogen
  • Developer Philogen; VU University Medical Center
  • Class Antineoplastics; Imaging agents; Monoclonal antibodies; Radiopharmaceuticals
  • Mechanism of Action Ionising radiation emitters
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Solid tumours

Most Recent Events

No Data Available
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top